Cspc Pharmaceutgr Adr4 Stock Profit Margin
| CVGU Stock | EUR 2.24 0.02 0.90% |
CSPC PHARMACEUTGR ADR4 fundamentals help investors to digest information that contributes to CSPC PHARMACEUTGR's financial success or failures. It also enables traders to predict the movement of CSPC Stock. The fundamental analysis module provides a way to measure CSPC PHARMACEUTGR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CSPC PHARMACEUTGR stock.
CSPC |
CSPC PHARMACEUTGR ADR4 Company Profit Margin Analysis
CSPC PHARMACEUTGR's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current CSPC PHARMACEUTGR Profit Margin | 0.19 % |
Most of CSPC PHARMACEUTGR's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSPC PHARMACEUTGR ADR4 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, CSPC PHARMACEUTGR ADR4 has a Profit Margin of 0.1868%. This is 101.67% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The profit margin for all Germany stocks is 114.71% lower than that of the firm.
CSPC Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CSPC PHARMACEUTGR's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CSPC PHARMACEUTGR could also be used in its relative valuation, which is a method of valuing CSPC PHARMACEUTGR by comparing valuation metrics of similar companies.CSPC PHARMACEUTGR is currently under evaluation in profit margin category among its peers.
CSPC Fundamentals
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.22 % | |||
| Shares Outstanding | 2.98 B | |||
| Price To Earning | 18.49 X | |||
| Revenue | 30.72 B | |||
| Gross Profit | 21.14 B | |||
| EBITDA | 7.56 B | |||
| Net Income | 5.47 B | |||
| Cash And Equivalents | 9.28 B | |||
| Cash Per Share | 3.10 X | |||
| Total Debt | 316.71 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 9.41 X | |||
| Earnings Per Share | 0.25 X | |||
| Number Of Employees | 24.75 K | |||
| Beta | 0.75 | |||
| Market Capitalization | 12.8 B | |||
| Z Score | 24.0 | |||
| Annual Yield | 0.03 % | |||
| Last Dividend Paid | 0.24 |
About CSPC PHARMACEUTGR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CSPC PHARMACEUTGR ADR4's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSPC PHARMACEUTGR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSPC PHARMACEUTGR ADR4 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CSPC Stock
CSPC PHARMACEUTGR financial ratios help investors to determine whether CSPC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC PHARMACEUTGR security.